Evolution and Innovations in Bone Marrow Cellular Therapy for Musculoskeletal Disorders: Tracing the Historical...

Area of Science:

• Regenerative Medicine
• Orthopedics
• Cellular Therapy

Background:

• Bone marrow cellular therapy has evolved significantly, with mesenchymal stem cells (MSCs) identified as key players in regenerative medicine.
• Early work by Friedenstein and Caplan established the foundation for understanding MSCs' differentiation and immunomodulatory capabilities.

Purpose of the Study:

• To review the historical evolution and contemporary advancements in bone marrow cellular therapy for musculoskeletal disorders.
• To highlight the therapeutic potential and clinical applications of bone marrow-derived MSCs.

Main Methods:

• Historical review of scientific literature and clinical studies.
• Analysis of research on mesenchymal stem cells (MSCs) derived from bone marrow.
• Examination of clinical trial outcomes and innovations in therapeutic techniques.

Main Results:

• Bone marrow-derived MSCs show promise in treating osteonecrosis, osteoarthritis, and tendon injuries by promoting tissue repair, modulating immunity, and enhancing angiogenesis.
• Clinical studies report significant improvements in pain relief, functional recovery, and tissue regeneration.
• Innovations like the ACH classification and improved aspiration methods have standardized practices, enhancing therapy efficacy.

Conclusions:

• Bone marrow-derived MSCs offer significant therapeutic potential for musculoskeletal conditions, with demonstrated benefits in reducing inflammation, supporting bone healing, and cartilage repair.
• Standardization of cell characterization and clinical trial reporting is crucial for advancing the field.
• Future research should explore integrating MSCs with other regenerative techniques and non-surgical applications for improved patient outcomes.